To address the problem, researchers suggested banning commission payments to drug reps for marketing opioids, stiffer monitoring of opioid advertisements and use of real-time electronic prescription databases to prevent overlapping prescriptions.
Researchers also suggested educational outreach programs to help physicians improve opioid prescribing and more research to guide practice. They said evidence on use of opioids to control chronic pain is very limited.
Related Articles on Opioids for Pain Management:
Global Pain Medication Sales Rise 8.9% Since 2005
Half of Patients Prescribed Opioids Still Taking Them Five Years Later
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.